Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Tafolecimab With Different Dosing Intervals in Patients With Hyperlipidemia

NCT07712042 is registered in ClinicalTrials.gov with Mei Gao as lead sponsor.

NCT NCT07712042
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07712042 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Tafolecimab With Different Dosing Intervals in Patients With Hyperlipidemia
Lead sponsor
Mei Gao
Phase
Observational
Overall status
Not yet recruiting
Start date
August 31, 2026
Completion date
December 31, 2028
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hyperlipidemia